Melanoma
From the Journals
Checkpoint inhibitors ‘viable treatment option’ in HIV-infected individuals
There were no concerning immune-mediated toxicities or changes in HIV-related parameters observed among 73 patients with HIV infection who had...
Conference Coverage
Immunotherapy’s cardiac effects require early monitoring, management
Immune checkpoint inhibitors and chimeric antigen receptor T cells can be highly effective against cancer, but can also harm the heart and...
Clinical Review
Targeted Therapy and Immunotherapy in the Treatment of Metastatic Cutaneous Melanoma
Conference Coverage
The personal cancer vaccine NEO-PV-01 shows promise in metastatic cancers
WASHINGTON – The NEO-PV-1 neoantigen vaccine plus poly-ICLC adjuvant and nivolumab is well tolerated and shows clinical activity in metastatic...
Case-Based Review
Cutaneous Melanoma
From the Journals
Poor-prognosis cancers linked to highest suicide risk in first year
Pancreatic and lung cancer patients had high rates of suicide in comparison to the general population, while breast and prostate cancer patients...
Latest News
Pembrolizumab approved for Merkel cell carcinoma
The FDA granted accelerated approval for the drug based on promising results in nonrandomized, open-label trial.
From the Journals
More data link severe sleep apnea and aggressive melanoma
The findings offer further evidence of the link between cancer and sleep-disordered breathing.
From the Journals
RCC strongly linked to melanoma, and vice versa
Clinicians need to be vigilant for RCCs in melanoma patients, and for melanomas in RCC patients.
Community Translations
